MEC Plus

The Future of Biomarkers of Immunotherapy in Cancer
The Future of Biomarkers of Immunotherapy in Cancer
Peter P. Lee, MD
How I Treat Multiple Myeloma
How I Treat Multiple Myeloma
Aaron S. Rosenberg, MD, MS
How I Treat Multiple Myeloma
How I Treat Multiple Myeloma
Aaron S. Rosenberg, MD, MS
How I Treat Locally Advanced Head and Neck Cancer
How I Treat Locally Advanced Head and Neck Cancer
A. Dimitrios Colevas, MD
PK and PD Considerations in Early Phase Clinical Trials
PK and PD Considerations in Early Phase Clinical Trials
Timothy Synold, PharmD
Bayesian Designs in Clinical Trials
Bayesian Designs in Clinical Trials
Mark Krailo, PhD
Waldenstrom’s Macroglobulinemia
Waldenstrom’s Macroglobulinemia
Andrew Branagan, MD, PhD
Waldenstrom’s Macroglobulinemia
Waldenstrom’s Macroglobulinemia
Andrew Branagan, MD, PhD
Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
William G. Wierda, MD, PhD
How To Approach A Newly Diagnosed Myeloma Patient?
How To Approach A Newly Diagnosed Myeloma Patient?
Saad Usmani, MD, MBA, FACP
Major Challenges Treating Myelodysplastic Syndrome
Major Challenges Treating Myelodysplastic Syndrome
Rami Komrokji, MD
CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!
CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP
De Novo Acute Myeloid Leukemia
De Novo Acute Myeloid Leukemia
Alexis M. Cruz Chacon, MD
De Novo Acute Myeloid Leukemia
De Novo Acute Myeloid Leukemia
Alexis M. Cruz Chacon, MD
New Approaches for Follicular Lymphoma
New Approaches for Follicular Lymphoma
Nakhle S. Saba, MD
DLBCL & Hodgkin’s Disease: Novel Approaches
DLBCL & Hodgkin’s Disease: Novel Approaches
Eduardo Sotomayor, MD